Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Stereotactic ablative radiotherapy (SABR) has been discovered to be a viable curative-intent therapy possibility amongst some sufferers with early-stage non-small cell lung most...
IER5L is upregulated in most cancersTo investigate the affiliation of IER relations (IER2, IER5 and IER5L) with tumor pathogenesis and development, we interrogated...
Bray, F. et al. International most cancers statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 international locations....
